Norepinephrine Infusion Combined With Goal-directed Fluid Therapy in Patients Undergoing Kidney Transplantations

NCT06367205 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

380

Enrollment

OTHER

Sponsor class

Conditions

Delayed Graft Function
End Stage Renal Disease
Kidney Transplantation

Interventions

DRUG: Goal-Directed Fluid Therapy (GDFT)
DRUG: Regular Fluid Therapy

Sponsor

RenJi Hospital